- Our Company
- CMF & Orthopedics
- Biomedical Manufacturing
- News & Events
OPM in the News
Now viewing articles posted in 2017.
August 25th, 2015
With FDA clearance for its 3-D printed patient-specific device for facial reconstruction, a South Windsor company is bringing new meaning to the term face-lift.
August 3rd, 2015
The Food and Drug Administration has granted 510(k) clearance to Oxford Performance Materials, Inc.’s SpineFab VBR Implant system. According to the company’s press release, OPM’s SpineFab system is the first and only FDA cleared 3D printed load-bearing polymer device for long-term implantation.
May 11th, 2015
Scott DeFelice is CEO and founder of Oxford Performance Materials, the first company to successfully 3D print with the high-performance poly-ether-ketone-ketone (PEKK) material.
March 19th, 2015
The term does not matter – additive manufacturing (AM) and 3D printing (3D) are interchangeable. Understanding the market, where it’s going, how it’s used, what it means to manufacturers, and who to turn to for more knowledge and support does…
January 12th, 2015
Oxford Performance Materials Inc. has launched the first two grades of its OXFAB 3-D printing technology suitable for aerospace and other industrial markets, including transportation, energy, and semiconductor applications.
December 11th, 2014
Oxford Performance Materials Inc., leader in additive manufacturing and advanced materials solutions, has launched the first two grades of its OXFAB 3D printing technology for aerospace and industrial applications.
December 11th, 2014
As Connecticut-based Oxford Performance Materials Inc. (OPM) has developed its 3D printing processes and materials, the company has simultaneously managed to create parts that are both biocompatible and aerospace compliant. Straddling the industries of medicine and aerospace, OPM is capable of printing jet engine parts that may be safe inside of one’s body and implants strong enough to fly in a fighter jet.
November 19th, 2014
Oxford Performance Materials Inc. has revealed it has received a three-year $150,000 grant from the National Institutes of Health to deliver new approaches in the treatment of infections related to implanted devices from advanced applications of 3D printed poly-ether-ketone-ketone.
October 8th, 2014
Scott Defelice, President and CEO of Oxford Performance Materials, drops in to talk about 3D printing medical devices and FDA regulation.